T regulatory lymphocytes in patients with endometriosis

Gogacz,Marek; Winkler,Izabela; Bojarska‑Junak,Agnieszka; Tabarkiewicz,Jacek; Semczuk,Andrzej; Rechberger,Tomasz; Adamiak,Aneta

doi:10.3892/mmr.2014.2294

T regulatory lymphocytes in patients with endometriosis

Authors:
- Marek Gogacz
- Izabela Winkler
- Agnieszka Bojarska‑Junak
- Jacek Tabarkiewicz
- Andrzej Semczuk
- Tomasz Rechberger
- Aneta Adamiak
View Affiliations

Affiliations: Second Department of Gynaecology, Medical University of Lublin, Lublin 20‑954, Poland, Department of Clinical Immunology, Medical University, Lublin 20‑093, Poland
Published online on: June 2, 2014 https://doi.org/10.3892/mmr.2014.2294
Pages: 1072-1076

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study aimed to investigate the presence of T regulatory cells (Tregs) in the peripheral blood (PB) and peritoneal fluid (PF) in females with endometriosis. The present study included 42 patients who underwent laparoscopy between 2010 and 2011. Flow cytometry was used to determine the percentage of Tregs in the PF and PB of the patients. No significant difference was observed in the percentage of Tregs in the patients in the endometriosis group compared with those in the control group in the PF (9.1±5.4 vs. 9.1±3.8%) or the PB (6.5±3.2 vs. 6.5±3.7%). However, the percentage of Tregs was found to be higher in the PF compared with the PB in the patients in the endometriosis and control groups, but significance was found only in those in the control group. Furthermore, no significant difference was observed in the Treg concentration in the patients with early stage (I/II) endometriosis compared with those with late stage (III/IV) endometriosis. Moreover, no significant correlation was found between the percentage of Tregs and the white blood cell count, lymphocyte count or CA125 concentration in the patients. These findings suggest that the local host‑defense mechanism is deficient in patients with endometriosis, thus endometriosis should not be treated as an autoimmune condition.

View Figures

View References

1	Olive DL and Schwartz LB: Endometriosis. N Engl J Med. 328:1759–1769. 1993. View Article : Google Scholar : PubMed/NCBI
2	Braun DP and Dmowski WP: Endometriosis: abnormal endometrium and dysfunctional immune response. Curr Opin Obstet Gynecol. 10:365–369. 1998. View Article : Google Scholar : PubMed/NCBI
3	Vinatier D, Dufour P and Oosterlynck D: Immunological aspects of endometriosis. Hum Reprod Update. 2:371–384. 1996. View Article : Google Scholar
4	Matarese G, De Placido G, Nikas Y and Alviggi C: Pathogenesis of endometriosis: natural immunity dysfunction or autoimmune disease? Trends Mol Med. 9:223–228. 2003. View Article : Google Scholar : PubMed/NCBI
5	Giudice LC and Kao LC: Endometriosis. Lancet. 364:1789–1799. 2004. View Article : Google Scholar : PubMed/NCBI
6	Nothnick WB: Treating endometriosis as an autoimmune disease. Fertil Steril. 76:223–231. 2001. View Article : Google Scholar : PubMed/NCBI
7	Sakaguchi S, Sakaguchi N, Asano M, Itoh M and Toda M: Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol. 155:1151–1164. 1995.
8	Sakaguchi S, Yamaguchi T, Nomura T and Ono M: Regulatory T cells and immune tolerance. Cell. 133:775–787. 2008. View Article : Google Scholar : PubMed/NCBI
9	Nandakumar S, Miller CW and Kumaraguru U: T regulatory cells: an overview and intervention techniques to modulate allergy outcome. Clin Mol Allergy. 7:52009. View Article : Google Scholar : PubMed/NCBI
10	Sakaguchi S, Ono M, Setoguchi R, et al: Foxp3⁺ CD25⁺ CD4⁺ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev. 212:8–27. 2006.
11	Rouse BT: Regulatory T cells in health and disease. J Intern Med. 262:78–95. 2007. View Article : Google Scholar : PubMed/NCBI
12	Kondělková K, Vokurková D, Krejsek J, Borská L, Fiala Z and Ctirad A: Regulatory T cells (TREG) and their roles in immune system with respect to immunopathological disorders. Acta Medica (Hradec Kralove). 53:73–77. 2010.PubMed/NCBI
13	Startseva NV and Shvetsov MV: The natural cellular cytotoxicity of endometriosis patients. Akush Ginekol (Mosk). 11:58–60. 1989.(In Russian).
14	Oosterlynck DJ, Cornillie FJ, Waer M, et al: Women with endometriosis show a defect in natural killer activity resulting in a decreased cytotoxicity to autologous endometrium. Fertil Steril. 56:45–51. 1991.
15	Steele RW, Dmowski WP and Marmer DJ: Immunologic aspects of human endometriosis. Am J Reprod Immunol. 6:33–36. 1984. View Article : Google Scholar
16	Dmowski WP, Gebel HM and Braun DP: The role of cell-mediated immunity in pathogenesis of endometriosis. Acta Obstet Gynecol Scand Suppl. 159:7–14. 1994.PubMed/NCBI
17	Jasper MJ, Tremellen KP and Robertson SA: Primary unexplained infertility is associated with reduced expression of the t-regulatory cell transcription factor Foxp3 in endometrial tissue. Mol Hum Reprod. 12:301–308. 2006. View Article : Google Scholar
18	Berbic M, Hey-Cunningham AJ, Ng C, et al: The role of Foxp3⁺ regulatory T-cells in endometriosis: a potential controlling mechanism for a complex, chronic immunological condition. Hum Reprod. 25:900–907. 2010.
19	Budiu RA, Diaconu I, Chrissluis R, Dricu A, Edwards RP and Vlad AM: A conditional mouse model for human MUC1-positive endometriosis shows the presence of anti-MUC1 antibodies and Foxp3⁺ regulatory T cells. Dis Model Mech. 2:593–603. 2009. View Article : Google Scholar : PubMed/NCBI
20	Zeitoun K, Takayama K, Sasano H, et al: Deficient 17-hydroxysteroid dehydrogenase type 2 expression in endometriosis: failure to metabolize 17beta-estradiol. J Clin Endocrinol Metab. 83:4474–4480. 1998.PubMed/NCBI
21	Prieto GA: Progression of endometriosis to cancer: too MUCh FoxP3⁺ regulatory T-cell response? Dis Model Mech. 4:139–140. 2011. View Article : Google Scholar : PubMed/NCBI
22	Mol BW, Bayram N, Lijmer JG, Wiegerinck MA, Bongers MY, van der Veen F and Bossuyt PM: The performance of CA-125 measurement in the detection of endometriosis: a meta-analysis. Fertil Steril. 70:1101–1108. 1998. View Article : Google Scholar : PubMed/NCBI
23	Gagné D, Rivard M, Pagé M, et al: Development of a nonsurgical diagnostic tool for endometriosis based on the detection of endometrial leukocyte subsets and serum CA-125 levels. Fertil Steril. 80:876–885. 2003.PubMed/NCBI